Prescription Drugs
Filters
Voriconazole (Vfend) 200/40mg | Pfizer Germany Originator | GLT
Pfizer originator Vfend (voriconazole) 200mg & 40mg tablets, broad-spectrum triazole antifungal for invasive aspergillosis and...
Fyarro (Sirolimus Albumin-bound) 100mg Injection | PEComa | GLT
Aadi Bioscience albumin-bound sirolimus for malignant PEComa
Hyftor (Sirolimus Gel) 0.2% 10g | TSC Facial Angiofibroma | GLT
Nobelpharma topical sirolimus gel for TSC facial angiofibroma
Ribociclib (Kisqali) 200mg*21's/14's | Novartis Switzerland | GLT
Novartis Switzerland originator Kisqali (ribociclib) 200mg, 21-tablet and 14-tablet packs for HR+/HER2- breast cancer.
Ribociclib (LuciRibo) 200mg*21's | Lucius Laos Generic | GLT
LuciRibo — Lucius Pharmaceuticals ribociclib 200mg 21 tablets for HR+/HER2- breast cancer.
Ribociclib (HER-2N) 200mg*21's | Julphar Bangladesh Generic | GLT
HER-2N — Julphar Bangladesh ribociclib 200mg 21 tablets, DGDA-certified, for HR+/HER2- breast cancer.
Lazertinib (Lazcluze) 80/240mg | Janssen US Originator | GLT
Janssen Biotech originator Lazcluze (lazertinib) 80mg & 240mg tablets, third-generation EGFR-TKI for EGFR-mutated NSCLC, US-sourced.
Lazertinib (Leclaza) 80mg | Yuhan Korea Originator | GLT
Yuhan originator Leclaza (lazertinib) 80mg x 84 tablets, the first Korean-developed third-generation EGFR-TKI for NSCLC.
Tizaro (Tirzepatide) 2.5/5/7.5/10/12.5/15mg/0.5mL Prefilled Syringe | Ziska Bangladesh | GLT
Tizaro — Ziska Pharmaceuticals tirzepatide prefilled syringe, six official strengths (2.5/5/7.5/10/12.5/15mg/0.5mL) for T2DM and weight...
Lazertinib (LuciLazer) 80mg | Lucius Laos Generic | GLT
LuciLazer (lazertinib) 80mg x 60 tablets by Lucius Pharmaceuticals Laos, cost-effective generic third-generation EGFR-TKI.
Pembrolizumab (Keytruda) 100mg/4mL | Japan PMDA-Approved PD-1 Inhibitor | GLT
PD-1 inhibitor for multiple cancers — Japan-sourced, PMDA-approved Keytruda at competitive global pricing
Pembrolizumab (Keytruda) 100mg/4mL & 50mg | US FDA-Approved PD-1 Inhibitor | GLT
PD-1 inhibitor for multiple cancers — US-sourced, FDA-approved Keytruda at competitive global pricing
Pembrolizumab (Keytruda) 100mg/4mL | Hong Kong Registered PD-1 Inhibitor | GLT
PD-1 inhibitor for multiple cancers — Hong Kong-registered Keytruda at competitive global pricing
Pemomab (Pembrolizumab) 100mg/4mL | Affordable PD-1 Inhibitor Biosimilar | GLT
PD-1 inhibitor biosimilar for multiple cancers — cost-effective pembrolizumab at accessible pricing
利舒仁（米托坦）500mg 100片 | Esteve 中国大陆 | GLT
利舒仁（Lysodren）——NMPA 批准米托坦，用于肾上腺皮质癌，中国大陆，Esteve Pharmaceuticals S.A.
排序
- 推荐
- 价格由低到高
- 价格由高到底
- 最新
- 销量最高